Marc Cartellieri
Chief Scientific Officer
Cellex Patient Treatment
Dr David Sourdive
Executive Vice President Technical Operations
Cellectis
Stefano Baila
Former Process Development Manager
Holding F.I.S.
Michaela Sharpe
Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult
Sarah Snykers
QC Manager
Celyad
Michaela Sharpe
Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult
Mark Aspinall O’Dea
EMEA Business Development Manager
Retogenix